Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Telesis Bio (TBIO) Stock Price & Analysis

140 Followers

TBIO Stock Chart & Stats

$0.01-$0.00(-8.33%)
At close: 4:00 PM EST
$0.01$0.02$0.03$0.04Sep 23Oct 7Oct 13Oct 15Oct 30
Day’s Range
$0.01 - $0.01
52-Week Range
$0.01 - $0.15
Previous Close
$0.01
Volume
N/A
Average Volume (3M)
162
Market Cap
$862.49K
Enterprise Value
$49.56M
Total Cash (Recent Filing)
$4.51M
Total Debt (Recent Filing)
$16.29M
Price to Earnings (P/E)
―
Beta
52.28
Next Earnings
N/A
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Innovative Product Offering

The company's focus on cutting-edge DNA synthesis technologies positions it well in the growing synthetic biology market, providing a durable competitive advantage.

Strategic Partnerships

Partnerships with biotech firms and research institutions enhance revenue potential and foster innovation, contributing to long-term growth.

Revenue Diversification

Diversified revenue sources reduce dependency on a single income stream, enhancing financial stability and resilience against market fluctuations.

Bears Say

High Leverage

Heavy reliance on debt financing increases financial risk and limits flexibility, potentially impacting long-term sustainability if not managed properly.

Negative Cash Flow

Persistent negative cash flow highlights challenges in operational efficiency, which may hinder the company's ability to invest in growth and innovation.

Declining Revenue

A significant decline in revenue suggests potential market share loss or reduced demand, posing a threat to long-term growth prospects.

Telesis Bio News

TBIO FAQ

What was Telesis Bio’s price range in the past 12 months?
Telesis Bio lowest stock price was $0.01 and its highest was $0.15 in the past 12 months.
What is Telesis Bio’s market cap?
Telesis Bio’s market cap is $862.49K.
When is Telesis Bio’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Telesis Bio’s earnings last quarter?
Telesis Bio released its earnings results on Nov 05, 2024. The company reported -$4.094 earnings per share for the quarter, beating the consensus estimate of -$5.3 by $1.206.
Is Telesis Bio overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Telesis Bio pay dividends?
Telesis Bio does not currently pay dividends.
What is Telesis Bio’s EPS estimate?
Telesis Bio’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Telesis Bio have?
Telesis Bio has 78,407,840 shares outstanding.
What happened to Telesis Bio’s price movement after its last earnings report?
Telesis Bio reported an EPS of -$4.094 in its last earnings report, beating expectations of -$5.3. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Telesis Bio?
Currently, no hedge funds are holding shares in TBIO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology